MX2017003604A - Solucion de dialisis. - Google Patents

Solucion de dialisis.

Info

Publication number
MX2017003604A
MX2017003604A MX2017003604A MX2017003604A MX2017003604A MX 2017003604 A MX2017003604 A MX 2017003604A MX 2017003604 A MX2017003604 A MX 2017003604A MX 2017003604 A MX2017003604 A MX 2017003604A MX 2017003604 A MX2017003604 A MX 2017003604A
Authority
MX
Mexico
Prior art keywords
dialysis solution
mmol
range
phosphate
calcium
Prior art date
Application number
MX2017003604A
Other languages
English (en)
Other versions
MX374865B (es
Inventor
Berlich Robert
HUPPERT Jochen
Mathis Pascal
Original Assignee
Fresenius Medical Care Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fresenius Medical Care Deutschland Gmbh filed Critical Fresenius Medical Care Deutschland Gmbh
Publication of MX2017003604A publication Critical patent/MX2017003604A/es
Publication of MX374865B publication Critical patent/MX374865B/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654Dialysates therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/42Phosphorus; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/287Dialysates therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10Carbonates; Bicarbonates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • External Artificial Organs (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a una solución de diálisis que contiene bicarbonato, calcio y fosfato, en donde la solución de diálisis contiene fosfato que tiene una concentración en el intervalo de hasta 0.4 mmol/l, de manera preferente en el intervalo de hasta 0.375 mmol/l, o en el intervalo de hasta 0.25 mmol/l, y particularmente de manera preferente en el intervalo de hasta 0.2 mmol/l.
MX2017003604A 2014-09-18 2015-09-15 Solución de diálisis. MX374865B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102014013885.2A DE102014013885A1 (de) 2014-09-18 2014-09-18 Dialyselösung
PCT/EP2015/001845 WO2016041634A1 (de) 2014-09-18 2015-09-15 Dialyselösung

Publications (2)

Publication Number Publication Date
MX2017003604A true MX2017003604A (es) 2017-06-27
MX374865B MX374865B (es) 2025-03-06

Family

ID=54147130

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017003604A MX374865B (es) 2014-09-18 2015-09-15 Solución de diálisis.

Country Status (12)

Country Link
US (1) US10835660B2 (es)
EP (1) EP3193833B1 (es)
KR (1) KR102464870B1 (es)
CN (1) CN106687108B (es)
AU (1) AU2015317229B2 (es)
CA (1) CA2961831C (es)
DE (1) DE102014013885A1 (es)
ES (1) ES2759308T3 (es)
MX (1) MX374865B (es)
PL (1) PL3193833T3 (es)
PT (1) PT3193833T (es)
WO (1) WO2016041634A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102018117264A1 (de) * 2018-07-17 2020-01-23 Fresenius Medical Care Deutschland Gmbh Verfahren zur Stabilisierung einer Dialyselösung
WO2020133198A1 (en) * 2018-12-28 2020-07-02 Fresenius Medical Care R&D (Shanghai) Co., Ltd. Stabilized aqueous hemofiltration basic solution, dialysis solution and corresponding kit
US20220226356A1 (en) * 2019-05-10 2022-07-21 Fresenius Medical Care Deutschland Gmbh Composition and Concentrate for Use in Preparation of Dialysis Solution, Corresponding Dialysis Solution and Combinations Comprising Container
CN121041450A (zh) * 2024-05-25 2025-12-02 上海交通大学医学院附属第九人民医院 含脂质组合物及在清除肝衰竭蛋白结合毒素中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60039978D1 (de) 1999-04-26 2008-10-02 Edwards Lifesciences Ag Substitutions-infusionflüssigkeit und zitratanticoagulation
SE0400522D0 (sv) * 2004-03-01 2004-03-01 Gambro Lundia Ab A medical solution, a method for producing said medical solution and use thereof
DE102004023828A1 (de) * 2004-05-13 2005-12-08 Fresenius Medical Care Deutschland Gmbh Lösung für die Peritonealdialyse
CN101861153A (zh) * 2007-08-15 2010-10-13 康利隆日本公司 腹膜透析液
US8771749B2 (en) * 2007-10-05 2014-07-08 National University Corporation Chiba University Stable bicarbonate ion-containing drug solution
US7658952B2 (en) * 2007-10-11 2010-02-09 Baxter International Inc. Dialysis solutions containing pyrophosphates
ES2332636B1 (es) * 2008-08-06 2011-02-10 Universitat De Les Illes Balears Composicion de liquido de dialisis.
JP5376480B1 (ja) * 2012-10-10 2013-12-25 富田製薬株式会社 酢酸及び酢酸塩を含む透析用a剤、及びそれを用いた2剤型透析用剤
WO2014177630A1 (en) * 2013-04-30 2014-11-06 Gambro Lundia Ab A multipart fluid system and a system for citrate anticoagualation in an extracorporeal blood circuit

Also Published As

Publication number Publication date
WO2016041634A1 (de) 2016-03-24
KR102464870B1 (ko) 2022-11-08
AU2015317229A1 (en) 2017-04-06
CN106687108A (zh) 2017-05-17
ES2759308T3 (es) 2020-05-08
MX374865B (es) 2025-03-06
US20170296729A1 (en) 2017-10-19
AU2015317229B2 (en) 2020-08-20
EP3193833A1 (de) 2017-07-26
KR20170062482A (ko) 2017-06-07
DE102014013885A1 (de) 2016-03-24
CA2961831C (en) 2022-12-06
PT3193833T (pt) 2019-09-10
CA2961831A1 (en) 2016-03-24
PL3193833T3 (pl) 2020-02-28
EP3193833B1 (de) 2019-07-31
CN106687108B (zh) 2021-09-14
US10835660B2 (en) 2020-11-17

Similar Documents

Publication Publication Date Title
CL2016002971A1 (es) Combinación.
CY1118168T1 (el) Διπλα ειδικα αντισωματα εναντι cd3εψιλον και bcma
MX370807B (es) Anticuerpos que se unen a axl.
EA201692105A1 (ru) Новые пиразолопиримидиновые производные и их применение в качестве ингибиторов malt1
EA201691991A1 (ru) Мультиспецифические антитела
BR112017011215A2 (pt) partículas de distribuição de pró-flavorizante
MX387665B (es) Péptidos, complejos, moléculas de carga y nanopartículas que contienen los mismos.
AR096478A1 (es) Composiciones para el tratamiento de superficie que comprenden tintes fotocromáticos
EA201790380A1 (ru) Ингибиторы mk2 и их применения
MX2017003205A (es) Composiciones antimicrobianas y sus metodos de uso.
EA201792612A1 (ru) 6-аминохинолин-3-карбонитрилы в качестве модуляторов cot
EA201791467A1 (ru) Водный офтальмологический раствор
EA201790312A1 (ru) Комбинации лекарственных средств для лечения множественной миеломы
AU359794S (en) Chain saw
AU361855S (en) Elevator bucket
EA201791174A1 (ru) Антимикотическое соединение
PH12017501071A1 (en) Dihydropyrimidin-2-one compounds and medical use thereof
MX2016010838A (es) Vacunas de proproteina convertasa subtilisina/kexina tipo 9 (pcsk9).
MX2017003604A (es) Solucion de dialisis.
AU359128S (en) Respirator cartridge having an engagement latch
CY1119212T1 (el) Χρηση του odiparcil στη θεραπεια μιας μυκοπολυσακχαριδωσης
MX385386B (es) Solucion de dialisis o solucion de sustitucion.
EE05766B1 (et) Meetod suure aktiivkloorisisaldusega desinfektsioonivahendi saamiseks läbivoolu diafragmaelektrolüüserist
UA94728U (uk) Магнітокерований сорбент для очищення біологічних рідин від комплексів цитостатиків
UA101750U (ru) Применение омега как органопротектора при токсическом гепатите

Legal Events

Date Code Title Description
FG Grant or registration